SCHEMBL6592246

SCHEMBL6592246

[CH2]C1CCC/C=C(/C)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CNR2 P34972 1/20 0.40
PPARA Q07869 1/20 0.40
LMNA P02545 5/20 0.38
TAS2R46 P59540 4/20 0.35
PKM P14618 2/20 0.35
RECQL P46063 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TERT O14746 1/20 0.35
ALDH1A1 P00352 4/20 0.31
TP53 P04637 3/20 0.31
CYP3A4 P08684 3/20 0.31
NLRP3 Q96P20 2/20 0.31
NFKB1 P19838 2/20 0.31
CYP1A2 P05177 2/20 0.31
STAT6 P42226 2/20 0.31
MAPT P10636 2/20 0.31
CASP1 P29466 1/20 0.31
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27496756 1.00 MEN1 (0.40) MEN1KMT2ACNR2PPARALMNA
SCHEMBL6592166 0.86
SCHEMBL6593471 0.83 MEN1 (0.36) MEN1KMT2ACNR2PPARALMNA
SCHEMBL6591686 0.80
SCHEMBL11309060 0.76 MEN1 (0.37) MEN1KMT2ACNR2PPARALMNA
SCHEMBL6592251 0.76 MEN1 (0.37) MEN1KMT2ACNR2PPARALMNA
SCHEMBL14761686 0.75 MEN1 (0.38) MEN1KMT2ACNR2PPARALMNA
SCHEMBL14761688 0.75 MEN1 (0.38) MEN1KMT2ACNR2PPARALMNA
SCHEMBL6590165 0.75
SCHEMBL3677592 0.74 LMNA (0.38) MEN1KMT2ACNR2PPARALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0823423-B1 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMA CO LTD (JP) 2004-06-16 EP disclosed
US-6140338-A FOR TREATING ACUTE INFLAMMATORY DISEASES, CHRONIC INFLAMMATORY DISEASES, ACQUIRED IMMUNE DEFICIENCY SYNDROME, CANCER, ISCHEMIC REFLOW DISORDER AND/OR ARTERIOSCLEROSIS BANYU PHARMACEUTICAL, CO., LTD. (JP) 2000-10-31 US disclosed
US-6040449-A USEFUL FOR FORMING FLUORINE CONTAINING 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES, USEFUL AS ANTAGONIST FOR MUSCARINIC M3 RECEPTORS AND LESS SIDE EFFECT BANYU PHARMACEUTICAL CO LTD (JP) 2000-03-21 US disclosed
US-5948792-A POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-09-07 US disclosed
EP-0930298-A1 FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-07-21 EP disclosed
EP-0916668-A1 CHEMOKINE RECEPTOR ANTAGONISTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-05-19 EP disclosed
US-5750540-A SIDE EFFECT REDUCTION BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
EP-0823423-A1 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 EP disclosed